Elevated activated partial thromboplastin time during administration of first-generation adenoviral vectors for gene therapy for prostate cancer: Identification of lupus anticoagulants-Reference-Cited by-同舟云学术

Elevated activated partial thromboplastin time during administration of first-generation adenoviral vectors for gene therapy for prostate cancer: Identification of lupus anticoagulants

Published:2005-10 Issue:4 Volume:66 Page:830-834
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Malaeb Bahaa S.,Gardner Thomas A.,Margulis Vitaly,Yang Ling,Gillenwater Jay Y.,Chung Leland W.K.,Macik Gail,Koeneman Kenneth S.

Publisher

Elsevier BV

Subject

Urology

Reference26 articles.

1. Chemogene therapy;Cheon;Cancer Gene Ther,1997

2. Osteomimetic properties of prostate cancer cells;Koeneman;Prostate,1997

3. Osteocalcin-directed gene therapy for prostate cancer bone metastasis;Koeneman;World J Urol,2000

4. Phase I dose escalation trial of adenovirus vector carrying osteocalcin promoter-driven herpes simplex virus thymidine kinase in localized and metastatic hormone-refractory prostate cancer;Kubo;Hum Gene Ther,2003

5. Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy;Sterman;Hum Gene Ther,1998

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functionalized lipoplexes and polyplexes for cancer therapy;Functionalized Nanomaterials for Cancer Research;2024

2. Safety and efficacy of the tumor-selective adenovirus enadenotucirev, in combination with nivolumab, in patients with advanced/metastatic epithelial cancer: a phase I clinical trial (SPICE);Journal for ImmunoTherapy of Cancer;2023-04

3. A tumor-selective adenoviral vector platform induces transient antiphospholipid antibodies, without increased risk of thrombosis, in phase 1 clinical studies;Investigational New Drugs;2023-03-10

4. Adenovirus-Based Vaccines and Thrombosis in Pregnancy: A Systematic Review and Meta-analysis;Clinical Infectious Diseases;2022-02-02

5. Antiphospholipid antibodies and risk of post-COVID-19 vaccination thrombophilia: The straw that breaks the camel's back?;Cytokine & Growth Factor Reviews;2021-08